I started my medical career as medical mycologist following the first case of deepseated candidiasis in Japan. On the other hand I have been seening many patients with tuberculosis as well as respiratory diseases.
In my sense the seening of mycobacterial infections may, still remain lot of clinical, biological or immunological research ideas in future. I did the studies on muramyl dipeptide (MDP) which derived from cell wall substance of mycobacteria.
MDP seemed to be one of the enhancing immunomodulator for host defense mechanism in particular in the immunocompromised host.
